Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago STEM News.
Press releases published on August 28, 2025

CryptoVirally Expands Web3 Marketing Services, Unifying PR, KOLs, and Community Growth Into One Full-Funnel Program
Bucharest, Romania, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CryptoVirally today announced an expanded suite of crypto marketing and Web3 marketing solutions that combine press releases, media placements, influencer and KOL activations, community growth, and …

Candel Therapeutics to Participate in Upcoming Investor Conferences in September
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …

IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company has regained compliance with the minimum bid price …

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CORAL GABLES, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …

EXL to participate in Citi Global TMT Conference in New York
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc., (NASDAQ: EXLS) announced today that Vivek Jetley, president and head of Insurance, Healthcare and Life Sciences and Maurizio Nicolelli, chief financial officer, will present at the Citi …

Biptap Expands to Africa with Central African Republic Deal
Dubai, UAE , Aug. 28, 2025 (GLOBE NEWSWIRE) -- Biptap expands to Africa with a landmark partnership in the Central African Republic, marking a major step toward redefining financial access across the continent. The deal, signed between Biptap CEO Jonathan …

Tidewave Bio Completes FDA INTERACT Meeting for TBC-1, a Universal Cell Therapy Platform in Solid Tumors
LOS ANGELES, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tidewave Bio, a biotechnology company developing a universal, off-the-shelf, gene-enhanced antigen-presenting cell therapy platform, today announced the successful completion of its FDA INTERACT meeting. This …

CytomX Therapeutics to Present at Upcoming September Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor …

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …

Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025 …

Easily Integrate Position, Navigation and Timing Technology With Microchip’s Portfolio of GNSS Disciplined Oscillator Modules
CHANDLER, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aerospace and defense applications rely on Position, Navigation and Timing (PNT) technology for mission-critical accuracy and reliability. However, integrating PNT into a design requires extensive domain …

Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
KYV-101 has the potential to deliver durable, drug-free, disease-free remission in myasthenia gravis and set a new treatment standard for stiff person syndrome Innovative FDA-aligned KYSA-6 Phase 3 trial design for myasthenia gravis supports clear and …

Fusemachines to Present at the 2025 Annual Gateway Conference on September 3rd
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Fusemachines, Inc. (“Fusemachines” or the “Company”), a leading provider of enterprise AI products and services, today announced its upcoming attendance of the 2025 Annual Gateway Conference, an institutional …

TG Therapeutics to Participate in the Cantor Global Healthcare Conference
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Cantor Global Healthcare Conference, being held in New York, …

RentRedi Delivers Fast, Flexible Financing, powered by Stripe Capital
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- RentRedi, the fastest-growing property management software for smart real estate investors, today announced the launch of a new financing solution powered by Stripe Capital that provides fast, flexible funding to …

NETCLASS TECHNOLOGY INC Announces Headquarters Relocation to Singapore and Planned Acquisition of Vietnam-based LBC International Company Limited
SHANGHAI and HONG KONG, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced …

Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences
Osteoporosis Program: Phase 2 analysis exploring the dual actions of oral PTH(1-34) tablet treatment, EB613 on trabecular and cortical bone, and Next-Gen EB613 PK/PD data slated for oral and poster presentations at ASBMR Short Bowel Syndome and Rare GI …

Psyence BioMed to Present at the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced …

Dog-Walker.io Announces DOGWALK Token Pre-Sale and Global Community Giveaway with a $500,000 Prize Pool
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Dog-Walker.io today announced the launch of the pre-sale for its native DogWalkerToken (DWT). The project, which combines blockchain technology with the pet care industry, has already attracted early interest from …

Crescent Biopharma to Present at September Investor Conferences
WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management …